收费全文 | 27219篇 |
免费 | 1425篇 |
国内免费 | 76篇 |
耳鼻咽喉 | 375篇 |
儿科学 | 2064篇 |
妇产科学 | 628篇 |
基础医学 | 3046篇 |
口腔科学 | 510篇 |
临床医学 | 1562篇 |
内科学 | 5179篇 |
皮肤病学 | 1006篇 |
神经病学 | 1232篇 |
特种医学 | 1003篇 |
外科学 | 4211篇 |
综合类 | 931篇 |
一般理论 | 12篇 |
预防医学 | 1296篇 |
眼科学 | 1336篇 |
药学 | 2240篇 |
中国医学 | 149篇 |
肿瘤学 | 1940篇 |
2023年 | 135篇 |
2022年 | 319篇 |
2021年 | 821篇 |
2020年 | 462篇 |
2019年 | 531篇 |
2018年 | 736篇 |
2017年 | 503篇 |
2016年 | 701篇 |
2015年 | 645篇 |
2014年 | 1013篇 |
2013年 | 1197篇 |
2012年 | 1695篇 |
2011年 | 1796篇 |
2010年 | 975篇 |
2009年 | 784篇 |
2008年 | 1332篇 |
2007年 | 1396篇 |
2006年 | 1220篇 |
2005年 | 1127篇 |
2004年 | 1012篇 |
2003年 | 924篇 |
2002年 | 821篇 |
2001年 | 724篇 |
2000年 | 683篇 |
1999年 | 599篇 |
1998年 | 245篇 |
1997年 | 180篇 |
1996年 | 144篇 |
1995年 | 137篇 |
1994年 | 115篇 |
1993年 | 131篇 |
1992年 | 356篇 |
1991年 | 390篇 |
1990年 | 342篇 |
1989年 | 358篇 |
1988年 | 309篇 |
1987年 | 277篇 |
1986年 | 268篇 |
1985年 | 280篇 |
1984年 | 220篇 |
1983年 | 181篇 |
1979年 | 241篇 |
1978年 | 158篇 |
1977年 | 148篇 |
1976年 | 135篇 |
1975年 | 163篇 |
1974年 | 154篇 |
1973年 | 176篇 |
1972年 | 138篇 |
1971年 | 122篇 |
Background
Multiple myeloma (MM) is a hematologic malignancy of plasma cell origin. MM primarily affects bone marrow, but extramedullary sites can also be involved. Myelomatous pleural effusion (MPE) is an atypical and rare complication of MM. We aimed to systematically study the incidence and clinicopathologic profile of patients with MPE in a real-world setting.Patients and Methods
In this retrospective study, 415 consecutive patients with MM managed at a tertiary care center in North India during a study period of January 1, 2010 to December 31, 2015 were evaluated for MPE. The patients with MPE were analyzed for their clinical profile, diagnosis, treatment, and outcomes.Results
Of these 415 patients, 11 (2.65%) patients had MPE. The median age of the study population was 50 years with male preponderance. The majority of these patients had immunoglobin (Ig)G Kappa disease. All patients had higher than International Staging System stage I disease. MPE was a presenting feature at MM diagnosis in 45.45% (n = 5) of the patients, whereas the rest developed MPE during follow-up. MPE presented predominantly (81.8%) as a unilateral effusion. Concurrent extramedullary involvement at other site was seen in 45.45% (n = 5), with 3 (27%) patients having concurrent myelomatous ascites. Six of these were managed aggressively, whereas 5 patients opted for palliation. The outcomes were dismal (90.9% mortality), with a median survival of 2.47 months.Conclusion
MPE is a rare entity, and positive outcomes of therapy remain low with dismal prognosis. 相似文献![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Robotic approaches have been steadily replacing laparoscopic approaches in metabolic and bariatric surgeries (MBS); however, their superiority has not been rigorously evaluated. The main goal of the study was to evaluate the 5-year utilization trends of robotic MBS and to compare to laparoscopic outcomes.
MethodsRetrospective analysis of 2015–2019 MBSAQIP data. Kruskal-Wallis test/Wilcoxon and Fisher’s exact/chi-square were used to compare continuous and categorical variables, respectively. Generalized linear models were used to compare surgery outcomes.
ResultsThe use of robotic MBS increased from 6.2% in 2015 to 13.5% in 2019 (N= 775,258). Robotic MBS patients had significantly higher age, BMI, and likelihood of 12 diseases compared to laparoscopic patients. After adjustment, robotic MBS patients showed higher 30-day interventions and 30-day readmissions alongside longer surgery time (26–38 min).
ConclusionRobotic MBS shows higher intervention and readmission even after controlling for cofounding variables.
Graphical Abstract